Ophthalmic magnetic resonance imaging: where are we (heading to)?

T Niendorf, JWM Beenakker, S Langner… - Current eye …, 2021 - Taylor & Francis
Magnetic resonance imaging of the eye and orbit (MReye) is a cross-domain research field,
combining (bio) physics,(bio) engineering, physiology, data sciences and ophthalmology. A …

Magnetic Resonance Imaging in the Clinical Care for Uveal Melanoma Patients—A Systematic Review from an Ophthalmic Perspective

MG Jaarsma-Coes, L Klaassen, M Marinkovic… - Cancers, 2023 - mdpi.com
Simple Summary In the past, eye tumours were generally not assessed with magnetic
resonance imaging (MRI) due to low image quality. MRI of the eye has significantly …

[HTML][HTML] Comparison of Magnetic Resonance Imaging–Based and Conventional Measurements for Proton Beam Therapy of Uveal Melanoma

MG Jaarsma-Coes, TA Ferreira, M Marinkovic… - Ophthalmology …, 2023 - Elsevier
Objective Conventionally, ocular proton therapy (PT) is planned using measurements
obtained by an ophthalmologist using ultrasound, fundoscopy, biometry, and intraoperative …

[HTML][HTML] MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy

R Via, A Pica, L Antonioli, C Paganelli, G Fattori… - Radiotherapy and …, 2022 - Elsevier
Abstract Introduction Ocular biometry in Ocular Proton Therapy (OPT) currently relies on a
generic geometrical eye model built by referencing surgically implanted markers. An …

[HTML][HTML] Inter-Observer variability in MR-based target volume delineation of uveal melanoma

MG Jaarsma-Coes, L Klaassen, BM Verbist… - Advances in Radiation …, 2023 - Elsevier
Purpose Several efforts are being undertaken toward MRI-based treatment planning for
ocular proton therapy for uveal melanoma (UM). The interobserver variability of the gross …

[HTML][HTML] PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy

J Hrbacek, A Kacperek, JWM Beenaker… - International Journal of …, 2024 - Elsevier
Although rare cancers, ocular tumors are a threat to vision, quality of life, and potentially life
expectancy of a patient. Ocular proton therapy (OPT) is a powerful tool for successfully …

[HTML][HTML] Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal …

L Klaassen, MG Jaarsma-Coes, BM Verbist… - Physics and Imaging in …, 2022 - Elsevier
Abstract Background and Purpose Three-dimensional (3D) Magnetic Resonance Imaging
(MRI) is increasingly used to complement conventional two-dimensional ultrasound in the …

[HTML][HTML] Improving organs-at-risk sparing for choroidal melanoma patients: a CT-based two-beam strategy in ocular proton therapy with a dedicated eyeline

E Fleury, P Trnková, C van Rij, M Rodrigues… - Radiotherapy and …, 2022 - Elsevier
Purpose To investigate the potential clinical benefit of a two-beam arrangement technique
using three-dimensional (3D) imaging of uveal melanoma (UM) patients treated with proton …

[HTML][HTML] Geometrical accuracy of magnetic resonance imaging for ocular proton therapy planning

L Klaassen, C Haasjes, M Hol, PC Lopes… - Physics and Imaging in …, 2024 - Elsevier
Background & purpose Magnetic resonance imaging (MRI) is increasingly used in treatment
preparation of ocular proton therapy, but its spatial accuracy might be limited by geometric …

Letter to the Editor of Radiotherapy and Oncology regarding the paper titled “MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy” …

JWM Beenakker, CRN Rasch - Radiotherapy and Oncology, 2022 - thegreenjournal.com
With great interest have we read the recent publication of Via et al.[1], who propose a
method to combine optical fundus photographs and magnetic resonance images (MRI) of …